Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Nov 22, 2016
EDEN PRAIRIE, Minn., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that on November 21, 2016 it received a letter from the Nasdaq Office of General Counsel indicating that the Panel had granted the Company continued listing on the Nasdaq Capital Market while i...

Read More

Posted on Nov 17, 2016
EDEN PRAIRIE, Minn., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. today announced that on November 11, 2016, the Company received a letter from the Nasdaq Listing Qualifications Staff indicating that the Company no longer satisfied the minimum $2.5 million stockholders' equity requiremen...

Read More

Posted on Nov 8, 2016
EDEN PRAIRIE, Minn., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results for the third quarter ended September 30, 2016. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an upd...

Read More

Events & Presentations

Posted on Nov 8, 2016 at 9:00 AM ET
Posted on Aug 24, 2016 at 11:45 AM CT
Posted on Aug 9, 2016 at 9:00 AM ET